News About: Pharm. Industry
Foggy future for CJ HealthCare’s disposal, but calmed atmosphere interally
The pharmaceutical industry is still highly interested in CJ HealthCare on market. This is because the company is a large company and one of the top 10 sales pharmaceutical companies, expected to be sold for about KRW...
Gilead Sciences appoints Executive Director Kwang-Gyu Park and Director Mi-Sun Yang
Gilead Sciences Korea(CEO Seung-Woo Lee) announced to appoint Executive Director Kwang-Kyu Park as Liver Disease Business Head and Director Mi-Sun Yang as HIV & Antifungal Business Head and Business Efficiency Divisio...
Which pharmaceutical companies made the largest collective sales?
On the 3rd quarter of this year, KOSDAQ pharmaceutical companies had a much higher increase rate of sales than the one of KOSPI pharmaceutical companies.
Yakup Shinmoon(www.yakup.com) analyzed sales that 34 KOSPI(Jei...
CrystalGenomics acquires Japanese patent of Acelex composition
CrystalGenomics(CEO Joong-Myung Cho) announced the company acquired a Japanese patent of ‘Acelex’ composition on the 24th of November.
“Acquisition of the patent extended the Acelex’s composition patent term to 2035....
Which listed company did record largest net profits?
By the 3rd quarter of this year, the KOSDAQ listed pharmaceutical companies’ collective net profits were 6 times larger than the one of the KOSPI market. In the net profit/sales rate, KOSDAQ listed pharmaceutical comp...
Sanofi, Huons Genexine with extended innovative pharmaceutical company certificate by 2020
Sanofi Aventis Korea, Genexine and Huons, the 3 companies’ innovative pharmaceutical company certificate will be extended to 2020. SK Chemicals, which recently had a corporate spin-off, was approved with the certifica...
Green Cross Labcell acquires U.S. patent of cell therapy mass production
Green Cross Labcell acquired a U.S. patent about mass production of cell therapy.
Green Cross Labcell(CEO Dae-Woo Park) announced on the 23rd that the company acquired a patent about culture method of natural killer ...
Pharma S decided to turn to accept returned medicines with no record
The issue of the pharmaceutical company S which sent back returned medicines with no shipping record has recently been addressed.
According to the distribution industry on the 24th, since the pharmaceutical company S...
Celltrion, Pharma Research, Whan In & Samjin record highest collective operating profit/sales rate in order
The KOSDAQ listed pharmaceutical companies’ year-on-year increase rate of operating profits on average is about twice higher than the one of KOSPI listed pharmaceutical companies. In regards to the collective 3rd quar...
Kwang Dong signs a Korean exclusive license agreement of female sexual desire disorder treatment
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 22nd that it signed a Korean exclusive license agreement of ‘bremelanotide,’ a substance candidate of novel drug developed by U.S. Palatin Technologies for...
